2010 Annual Scientific Meeting and Exposition 2010 Annual ...

More documents

Recommendations

Info

ASH Program at a GlanceSunday, May 2, 20106:00 AM7:00 AMTrianonBallroomSatellite Symposium:The Journey to OptimalTreatment Strategiesfor the OA Patient withHypertensionWestBallroomBeekmanParlorSuttonNorthMercuryBallroomMorganSuiteBryantSuiteClintonSuiteGibsonSuiteRhinelanderGalleryEastBallroomAmericasHall I8:00 AM9:00 AM10:00 AM11:00 AM12:00 PM1:00 PM2:00 PM3:00 PM4:00 PM5:00 PMHypertension for thePrimary Care Clinician2010Session:Overviews in VascularFunction andClinicalPharmacologySession:Improving RegionalCardiovascular OutcomesMeet the Expert:How to Interpret a ClinicalTrial ManuscriptSession:Cardio-MetabolicAbnormalitiesin ArterialHypertensionSession:The Emerging Roleof Aldosterone inHypertensionMeet the Expert:Angiotensin 1-7. Is itRelevant?Session:ALLHAT: Long-termOutcomes of DrugTreatment in High CHD RiskHypertensive PatientsSession:Aging and AtherosclerosisMeet the Expert:Update and Results onWomen’s Health InitiativeMeet the Expert:Pharmacokinetics,PharmacodynamicsMeet the Expert:Management of LowHDL CholesterolMeet the Expert:Vascular FunctionMeet the Expert:Isolated SystolicHypertensionMeet the Expert:Imaging for SecondaryCauses of HypertensionMeet the Expert:Hypertension and AirPollutionMeet the Expert:Peripheral Vascular DiseasePoster HallClinical Cases:Resistant Hypertension:Non-Drug ApproachesPosters on Display from9:00 AM to 6:45 PMPoster Viewing from4:45 PM to 5:45 PMFeatured Posters;Blood PressureMeasurement/Monitoring;Heart Failure/Hypertrophy;Kidney and Hypertension;Metabolic Syndrome;Non-PharmacologicalTherapy;Patient-Provider-HealthcareSystem Issues;Risk Factors;Pregnancy.Cardiovascular Risk in theYoung AthleteSession:Plenary Session I:Hypertension in the21st CenturySession:Secondary Hypertension:Causes and ComplicationsHypertensionResource PavilionOpen from9:00 AM to 12:00 PMHypertensionResource PavilionOpen from 3:30 PM to6:45 PMHigh Tea from 4:45 PM to5:45 PM.6:00 PM7:00 PMSession:Non-Cardiac Drugs thatRaise Blood PressureSession:Cornerstones of theEuropean and AmericanGuidelines –Session:Hypertension andOxidative StressandDrug InteractionSession:Blood Pressure Goals:Novel Approaches8:00 PM9:00 PM9:30 PMSatellite Symposium:Exploring the Futureof CombinationAntihypertensive Therapy:Is There a Limit to theNumber of Drugs in aFixed-Dose Combination?Similarities andDifferencesSatellite SymposiaScientific SessionsSpecial EventPrimary Care SessionClinical Case DiscussionsMeet the Expert SessionsPoster SessionsHypertension Resource Pavillion44
ASH Program at a GlanceMonday, May 3, 20106:00 AM7:00 AMTrianonBallroomSatellite Symposium:Targeting EndothelialDysfunction in HypertensiveCardiovascular Disease:Why, When, and HowMercuryBallroomEastBallroomWestBallroomSuttonNorthBryantSuiteGibsonSuiteMorganSuiteRhinelanderGalleryAmericasHall I8:00 AM9:00 AM10:00 AM11:00 AMSession:The Genetic Basis ofHypertensionSession:Renal Mechanisms ofHypertensionSession:Biomarkers andCardiovascular Risk: NovelMethods of AssessmentSession:Cardiometabolic Syndrome:New Insights about RiskReductionSession:Hypertension as a SilentPrelude to Heart FailureSession:Complications of theHypertensive DiseaseProcessSession:Assessing ArterialStiffness to Improvethe Management ofCardiovascular Disease inthe 21st CenturyPoster HallPosters on Display from9:00 to 5:15 PMPoster Viewing from 4:15PM to 5:15 PMHypertensionResource PavilionOpen from9:00 AM to 1:00 PM12:00 PMMeet the Expert:Metabolic Syndrome andPolycystic Ovary SyndromeMeet the Expert:Renal Sympathetic NervesMeet the Expert:The Treatment of AtrialFibrillation in theMeet the Expert:Exercise TestingClinical Cases:Hypertension Emergenciesand Urgencies1:00 PM2:00 PM3:00 PM4:00 PM5:00 PMSession:Plenary Session II:Awards Presentationsand State-of-the-ArtLecturesHypertensivePatientCellular Mechanisms;Clinical Trials; EndothelialFunction; Epidemiology/Special Populations;Genetics/Gene Therapy/Proteomics; NeuralHormonal Mechanisms;Obesity; PediatricHypertension; PreclinicalModels/ExperimentalHypertension; VascularInjury/Inflammation andRemodeling;Late-Breaking Posters.Etiological Approach toObesity Assessment andManagementHypertensionResource PavilionOpen from3:30 PM to 5:15 PMHigh Tea from4:45 PM to 5:15 PM.6:00 PM7:00 PM8:00 PM9:00 PMSatellite Symposium:A Cross Examination ofContemporary Issues inHypertension: Today’sControversy and Consensus9:30 PMSatellite SymposiaScientific SessionsSpecial EventClinical Case DiscussionsMeet the Expert SessionsPoster SessionsHypertension Resource Pavillion45
Page 1 and 2: American Society of Hypertension201
Page 3 and 4: Valturna offers bothsuperior BP eff
Page 5 and 6: Figure 2: Probability of Achieving
Page 7 and 8: potential for other drugs acting on
Page 9 and 10: aliskiren arms were about one-third
Page 11 and 12: As with other drugs that block angi
Page 13: American Society of Hypertension201
Page 18: Program Color KeyThe pages of this
Page 21 and 22: General InformationThis program boo
Page 23 and 24: General Information continuedHilton
Page 25 and 26: General Information continuedASH Sc
Page 27 and 28: General Information continuedASH Hy
Page 29 and 30: 2010 ASH Corporate MembersBoehringe
Page 31 and 32: ASH Leadership2009-2010 Board of Di
Page 33 and 34: Special LectureMonday, May 3, 2010,
Page 35 and 36: Special LectureMonday, May 3, 2010,
Page 37 and 38: 2010 Abstract Reviewers continuedEr
Page 39 and 40: Visit TEKTURNA at Booth 1100.and/or
Page 41 and 42: 5.5 HyperkalemiaIncreases in serum
Page 43 and 44: with Pgp substrates or weak to mode
Page 45: ASH Program at a GlanceSaturday, Ma
Page 49 and 50: Poster Category PresentationPosters
Page 51 and 52: 2010 ASH Faculty continuedJeffrey R
Page 53 and 54: 2010 ASH Faculty continuedAndrew Wh
Page 55 and 56: 2010American Societyof Hypertension
Page 57 and 58: Saturday Afternoon MAY 1PostersPost
Page 59 and 60: Saturday Afternoon MAY 1Sessions3:3
Page 61 and 62: Saturday Afternoon MAY 1Sessions3:3
Page 63 and 64: Sunday Morning MAY 2Satellite Sympo
Page 65 and 66: Sunday Morning MAY 2Sessions contin
Page 67 and 68: Sunday Morning MAY 2Sessions8:00 AM
Page 69 and 70: Sunday Morning MAY 2Sessions10:00 A
Page 71 and 72: Sunday Morning MAY 2Sessions10:00 A
Page 73 and 74: Sunday Afternoon MAY 2Sessions3:30
Page 75 and 76: Sunday Afternoon MAY 2Sessions3:30
Page 77 and 78: Sunday Afternoon MAY 2Special Sessi
Page 79 and 80: Sunday Evening MAY 2Sessions6:00 PM
Page 81 and 82: Sunday Evening MAY 2Sessions6:00 PM
Page 83 and 84: Monday Morning MAY 3Satellite Sympo
Page 85 and 86: Monday Morning MAY 3Sessions8:00 AM
Page 87 and 88: Monday Morning Afternoon MAY 21 3Po
Page 89 and 90: Monday Morning MAY 3Sessions10:00 A
Page 95 and 96: Monday Evening May 3Satellite Sympo
Page 97 and 98:
Tuesday Morning May 48:45 AM LB-OR-
Page 99 and 100:
Tuesday Morning May 4Sessions8:00 A
Page 101 and 102:
Tuesday Morning MAY 4ASH Membership
Page 103 and 104:
Tuesday Morning MAY 4Sessions10:55
Page 105 and 106:
2010American Societyof Hypertension
Page 107 and 108:
Saturday Afternoon MAY 1Posters3:00
Page 109 and 110:
Saturday Afternoon MAY 1PostersPO-2
Page 111 and 112:
Page 113 and 114:
Page 115 and 116:
Page 117 and 118:
Page 119 and 120:
Page 121 and 122:
Page 123 and 124:
Page 125 and 126:
Sunday Morning MAY 2PostersPosters
Page 127 and 128:
Sunday Morning MAY 2Posters9:00 AM
Page 129 and 130:
Sunday Morning MAY 2PostersPO-123:
Page 131 and 132:
Page 133 and 134:
Page 135 and 136:
Page 137 and 138:
Page 139 and 140:
Page 141 and 142:
Page 143 and 144:
Monday Morning Afternoon MAY 21 3Po
Page 145 and 146:
Page 147 and 148:
Page 149 and 150:
Page 151 and 152:
Page 153 and 154:
Page 155 and 156:
Page 157 and 158:
Page 159 and 160:
Page 161 and 162:
Monday Morning Afternoon May 213Pos
Page 163 and 164:
Faculty Disclosure ListingGail Adle
Page 165 and 166:
Faculty Disclosure Listing continue
Page 167 and 168:
Page 169 and 170:
Page 171 and 172:
Page 173 and 174:
you to attend thethe Innovations Th
Page 175 and 176:
5.5 HyperkalemiaIncreases in serum
Page 177 and 178:
with Pgp substrates or weak to mode
Page 179 and 180:
Valturna (aliskiren and valsartan,
Page 181 and 182:
4 CONTRAINDICATIONSNone.5 WARNINGS
Page 183 and 184:
een reported. In a 4-day trial of v
Page 185 and 186:
7 DRUG INTERACTIONSNo drug interact
Page 187 and 188:
8.5 Geriatric UseIn 8.5the Geriatri
Page 189 and 190:
2010 ASH ExhibitorsASH Hypertension
Page 191 and 192:
ASH Hypertension Resource CenterHil
Page 193 and 194:
2010 ASH Exhibitors continuedCVRx I
Page 195 and 196:
2010 ASH Exhibitors continuedIntern
Page 197 and 198:
2010 ASH Exhibitors continuedNature
Page 199 and 200:
2010 ASH Exhibitors continuedRESPeR
Page 201 and 202:
Author IndexAAbaunza, Ricardo, 122A
Page 203 and 204:
Author IndexCastellano, Maurizio, 1
Page 205 and 206:
Author IndexGuarneri, Marco, 146Guo
Page 207 and 208:
Author IndexLekakis, John, 118, 122
Page 209 and 210:
Author IndexPittaras, Andreas, 149P
Page 211 and 212:
Author IndexTello, Susana, 109, 135
Page 213 and 214:
Hilton New York Floor PlansSecond F
Page 215 and 216:
Hilton New York Floor PlansFourth F
Page 218:
Are You 1in 3?Get the facts. Know y
show all

2010 Annual Scientific Meeting and Exposition 2010 Annual ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?